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Background: Bronchopulmonary dysplasia (BPD) is the most common serious pulmonary morbidity in premature
infants. The score for neonatal acute physiology (SNAP) is a physiologic severity index for neonatal intensive care
and correlates well with neonatal mortality and clinical outcomes. The prognostic value of the SNAP score for BPD
in preterm infants remains to be clarified. The aim of the study was to determine whether SNAP can predict the
development of BPD or death, and to investigate the contribution of SNAP to the predictive accuracy of other
potential perinatal risk factors for the adverse outcome in critically ill preterm infants.
Methods: We conducted a study in 160 critically ill preterm infants with less than 33 gestational weeks. The
original SNAP score was prospectively calculated based on 28 items collected during the first 24 hours of
admission. The potential perinatal risk factors were assessed during the first 72 hours of life. Major outcome
measures were BPD and mortality before the time of BPD screening.
Results: Of the 160 infants, 17 died and 41 developed BPD. The SNAP score was significantly associated with BPD
or death (odds ratio [OR] =1.28; 95% confidence interval [CI], 1.16-1.41; p <0.001), even after adjustment for
gestational age (OR =1.27; 95% CI, 1.13-1.41; p <0.001). High SNAP score was an independent predictor of BPD or
death (area under the curve [AUC] =0.78; 95% CI, 0.70-0.85; p <0.001), with additional predictive value when
combined with other perinatal risk factors. Multivariate regression analysis resulted in a final model, including SNAP,
gestational age, apnea of prematurity, patent ductus arteriosus, and surfactant use as independent risk factors, with
a higher predictive accuracy compared with individual components (AUC =0.92; 95% CI, 0.87-0.96; p <0.001).
Conclusions: SNAP is associated with adverse outcome of BPD or death. High SNAP scores are predictive of BPD or
death in critically ill preterm infants, and add prognostic value to other perinatal risk factors.
Keywords: Adverse outcome, Bronchopulmonary dysplasia, Critically ill preterm infants, Mortality, Perinatal risk
factors, Predictive test, SNAP (the score for neonatal acute physiology)Background
Bronchopulmonary dysplasia (BPD) is the most common
serious pulmonary morbidity in premature infants [1-4].
Although there was a lack of universally acceptable ac-
curate predictive models of BPD in clinical practice and
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reproduction in any medium, provided the orfactorial disorder, with low gestational age, low birth
weight, lower Apgar scores, longer duration of oxygen
exposure and assisted mechanical ventilation, and the
presence of sepsis and patent ductus arteriosus (PDA)
being important risk factors [5-10].
Illness severity scores have been widely used to adjust
outcomes between populations for quality improvement
and research purposes [11-15]. The score for neonatal
acute physiology (SNAP) is a physiologic severity index
for neonatal intensive care. SNAP is based on 28 items
collected over the first 24 hours of life, and applicable to
any infant admitted to a neonatal unit [11].his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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measure of illness severity at admission and important
predictor of neonatal mortality and clinical outcomes
[12,16-19]. However, to the best of our knowledge, no
study has investigated the association between SNAP
and the development of BPD. The predictive value of
SNAP in critically ill preterm infants in relationship to
BPD is currently unknown. In addition, mortality is a com-
peting outcome for BPD. When identifying risk factors, the
outcome of BPD/death should be used rather than BPD
alone [9,20,21]. We hypothesized that in neonates SNAP
could predict the development of BPD or death. The goal
of this study was to investigate the contribution of SNAP
to the predictive accuracy of other perinatal risk factors for
the adverse outcome in critically ill preterm infants. It is
clinically significant to evaluate additional predictive value
by combining SNAP with other perinatal risk factors. Clini-
cians might be able to accurately predict BPD or death
when taking account of the full and changing clinical pic-
ture of an infant.
Methods
This study included preterm infants with less than 33 gesta-
tional weeks admitted to the neonatal intensive care unit
(NICU) during the period from July 2010 to May 2012.
Infants greater than 33 weeks of gestational age were not
included because less than 1% of them developed BPD. The
exclusion criteria were as follows: infants admitted to NICU
after 24 hours of life, infants unexpectedly discharged
or transferred to other departments or hospitals, and in-
fants with severe congenital anomalies. The Institutional
Ethics Review Board of the Children’s Hospital affiliated to
Soochow University approved the study. Informed consent
was obtained from the parents of the infants.
Potential perinatal risk factors
To investigate the early prediction of BPD or death, the
potential perinatal risk factors obtained during the first
72 hours of life were studied. Maternal data including
chorioamnionitis, premature rupture of the membranes
(PROM) >24 hours, gestational diabetes mellitus (GDM),
pre-GDM, hypertension, pre-eclampsia, antenatal steroids,
and mode of delivery, as well as neonatal data including
gestational age, birth weight, gender, the Apgar scores,
and delivery room resuscitation course were collected.
Antenatal steroids were considered to have been adminis-
tered if at least one dexamethasone injection was given
12 hours before delivery. Gestational age was calculated
from the mother’s menstrual history and was confirmed
by ultrasonography.
Clinical status, medication, and therapeutic interven-
tions of the infants were recorded daily during the first
72 hours of life. We evaluated all infants for the presence
of perinatal asphyxia, respiratory distress syndrome (RDS),transient tachypnea of the newborn, apnea of prematurity,
pneumothorax, pulmonary hemorrhage, PDA, early onset
sepsis, necrotizing enterocolitis (NEC), hypoxic-ischemic
brain damage, intraventricular hemorrhage (IVH), and
acute kidney injury.
In addition, we examined the use of postnatal steroids
and surfactants at any time during the first 72 hours of
life. Respiratory support, including oxygen, continuous
positive airway pressure (CPAP), invasive mechanical
ventilation, and the duration of therapies, were recorded.
We assigned the respiratory support as none, nasal can-
nula, nasal CPAP, or invasive mechanical ventilation.
The SNAP score
The original SNAP score was prospectively calculated
for each infant based on 28 items collected during the
first 24 hours of admission, including blood pressure,
heart rate, respiratory rate, temperature, partial pressure
arterial oxygen/fractional inspired oxygen (PaO2/FiO2)
ratio, PaO2, partial pressure of carbon dioxide (PaCO2)
in arterial blood, oxygenation index, hematocrit, white
blood cell count, immature total ratio, absolute neutro-
phil count, platelet count, blood urea nitrogen, serum
creatinine (Cr), urine output, serum indirect bilirubin,
serum direct bilirubin, serum sodium, serum potassium,
serum ionized calcium, serum total calcium, serum glu-
cose, serum bicarbonate, arterial pH, seizure, apnea, and
stool guaiac [11]. All the data were prospectively col-
lected by trained graduate students under the supervi-
sion of the attending neonatologists and the chief of
neonatology.
Clinical outcomes
The outcome measures included the development of
BPD or death before the time of BPD screening [20].
Definition of BPD
Infants were categorized as having mild, moderate, or se-
vere BPD, according to the National Institutes of Health
consensus definition of BPD [5,22]. Mild BPD was defined
as receiving supplemental oxygen for ≥28 days but not at
a postmenstrual age (PMA) of 36 weeks or at discharge;
moderate BPD as receiving oxygen for ≥28 days plus treat-
ment with <30% oxygen at 36 weeks’ PMA; and severe
BPD as receiving oxygen for ≥28 days plus ≥30% oxygen
and/or positive pressure at 36 weeks’ PMA.
Diagnostic criteria and clinical indications
Apnea of prematurity was defined as cessation of breath-
ing that lasts more than 15 seconds and is accompanied
by bradycardia or hypoxia [23]. Diagnosis of PDA was
based on echocardiogram and color Doppler test. PDA
was considered as significant when the following cri-
teria were met, as described previously: (a) a ductal
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of more than 300 ml/kg/min; (c) left atrium to aortic root
ratio greater than 1.5; (d) retrograde or absent diastolic
flow in the cerebral anterior artery or in the descending
thoracic aorta [24]. The criteria for the diagnosis of RDS
were in accordance with the European consensus on the
management of neonatal RDS in preterm infants. The
diagnosis was confirmed on chest x-ray with a classical
‘ground glass’ appearance and air bronchograms. Infants
with or at high risk of RDS were given a natural surfactant
preparation [25,26]. Perinatal asphyxia was defined ac-
cording to the following criteria: (1) pH ≤ 7.0 or base def-
icit ≥ 16 mmol/l in cord blood or during the first 1 hour
after birth; or (2) If the pH was between 7.01 and 7.15, or
the base deficit was between 10 and 15.9 mmol/L, or an
arterial blood gas value was not available, either a 10 min-
Apgar score ≤ 5 or assisted ventilation for ≥ 10 minutes
from birth was required [27]. Once these criteria were
met, all neonates underwent a standardized neurologic
examination performed by neonatologists. Encephalopathy
was defined as the presence of one or more signs in at
least three of the following six categories (1) level of con-
sciousness; (2) spontaneous activity; (3) posture; (4) tone;
(5) primitive reflexes; and (6) autonomic nervous system
signs [28]. Preterm infants who met the criteria for diag-
nosis of encephalopathy were considered as having
hypoxic-ischemic brain damage, and diagnosis was con-
firmed by MRI examination. Diagnosis of IVH was
based on the findings on head ultrasound and/or MRI
according to the criteria of Papile et al. [29]. A head
ultrasound was routinely performed in all preterm in-
fants and in infants diagnosed with perinatal asphyxia.
A brain MRI was conducted only in preterm infants
who presented with signs and symptoms suggestive of
encephalopathy or brain damage during the hospita-
lization, as described in our previous study [30]. The
NEC diagnosis was made according to the modified
Bell’s staging criteria. Infants with stage II or greater
were defined as having NEC [31,32]. The diagnostic cri-
teria of sepsis were in accordance with our previous
study. Infants with positive clinical and/or laboratory
screen and positive culture were defined as having sep-
sis [33]. EOS refers to sepsis presenting in the first
72 hours of life [34]. The diagnosis of AKI was based on
serum Cr >1.5 mg/dl (132.6 μmol/l) and/or a ≥150% in-
crease in serum Cr from baseline [33,35,36].
The indication for oxygen therapy in the newborn was
PaO2 <50 mm Hg (6.6 kPa) or transcutaneous oxygen
saturation <85% in room air, except in the presence of
cyanotic congenital heart disease. Inability to maintain
oxygenation with nasal cannula (FiO2 >60% to maintain
PaO2 >50 mm Hg or arterial blood pH <7.25) or apnea
unresponsive to stimulation is an indication for CPAP.
The indications for mechanical ventilation were respiratoryfailure in newborns: PaO2 <50 mm Hg on FiO2 >60%,
PaCO2 >60 mm Hg (8.0 kPa), arterial pH <7.20 or
prolonged or repetitive unresponsive apnea associated with
bradycardia or cyanosis.
Statistical analysis
Statistical analyses were performed with SPSS 13.0. Bi-
variate and multivariate logistic regression was per-
formed to identify potential perinatal risk factors
associated with adverse outcome. Variables with p <0.2
in the bivariate analysis were entered into a backward
stepwise multivariate regression model. Model fit was
assessed with the Hosmer-Lemeshow goodness-of-fit test.
A non-significant value for the Hosmer-Lemeshow Chi-
square test suggests an absence of biased fit. Analysis of
the area under the curve (AUC) of the Receiver Operating
Characteristic (ROC) curve was constructed to assess the
prognostic performance. The nonparametric method of
Delong was used to compare significant difference be-
tween AUCs (Sigmaplot 10.0 software). Sensitivity and
specificity were also determined. All probability values are
two-sided. Differences with p values <0.05 were consid-
ered to be statistically significant.
Results
A total of 160 infants were included in this study. During
the time period of the study, 207 preterm infants with less
than 33 gestational weeks were admitted to NICU during
the first day of life. Forty-seven infants were excluded: 2
were diagnosed with severe congenital anomalies, 1 was
transferred to another department, and 44 were unexpect-
edly discharged because of economic reasons.
Of the total 160 preterm infants, 17 died before the
time of BPD screening. Among the 143 survived in-
fants, 41 fulfilled the criteria for the diagnosis of BPD,
including 25 with mild, 9 with moderate, and 7 with se-
vere BPD. Patient characteristics of survivors without
BPD and infants who died or developed BPD are shown
in Table 1. In addition, there was no significant differ-
ence between included and excluded preterm infants
with regards to gestational age (31.00 [25.86-32.86] vs
30.86 [24.00-32.86] weeks, p =0.797), birth weight
(1460 [670–2320] vs 1550 [850–2300] g, p =0.285),
gender (male/female: 104/56 vs 30/14, p =0.724), SNAP
(10 [3-27] vs 9 [3-16], p =0.146), 1 min-Apgar score ( 8
[1-10] vs 8 [5-10], p =0.841), 5 min-Apgar score (9 [2-
10] vs 8.5 [6-10], p =0.476), and oxygen therapy during
the first 72 hours (p >0.05).
Bivariate analysis of risk factors for the development of
BPD or death
Data from all preterm infants were analyzed to predict
BPD or death. Preterm infants with mild BPD were in-
cluded into the group of BPD or death. There was no
Table 1 Patient characteristics and bivariate analysis of perinatal risk factors for BPD or death*
Survival without BPD (n = 102) BPD or Death (n = 58) Odds ratio (95%)# P value
Gestational age, weeks 31.86 [28.29-32.86] 29.29 [25.86-32.29] 0.41 (0.31-0.55) <0.001
Birth weight, g 1570 [900–2320] 1330 [670–2100] 0.81 (0.72-0.90)a <0.001b
Gender, male/female 67/35 37/21 1.09 (0.55-2.13) 0.809
Small for gestational age (<10%), n (%) 12 (11.8) 9 (15.5) 1.38 (0.54-3.50) 0.500
Apgar score, 1 min 8 [1-10] 7 [1-10] 0.90 (0.77-1.04) 0.139
Apgar score, 5 min 9 [3-10] 8.5 [2-10] 0.76 (0.63-0.93) 0.007c
SNAP 8 [3-26] 13 [4-27] 1.28 (1.16-1.41)d <0.001c
Apnea of prematurity, n (%) 12 (11.8) 18 (31.0) 3.23 (1.42-7.33) 0.005b
Patent ductus arteriosus, n (%) 1 (1.0) 8 (13.8) 16.33 (1.99-134.2) <0.001c
Respiratory distress syndrome, n (%) 45 (44.1) 50 (86.2) 8.89 (3.68-21.49) <0.001c
Hypoxic-ischemic brain damage, n (%) 7 (6.9) 2 (3.4) 0.49 (0.10-2.43) 0.382
Intraventricular hemorrhage, n (%) 0 (0) 3 (5.2) 3E + 009 0.999
Early-onset sepsis, n (%) 4 (3.9) 2 (3.4) 0.88 (0.16-4.97) 0.887
Respiratory supporte 2.95 (1.89-4.61) <0.001c
Oxygen therapy, n (%) 85 (83.3) 57 (98.3) 9.39 (1.20-73.39) 0.033b
CPAP, n (%) 45 (44.1) 30 (51.7) 1.16 (0.60-2.25) 0.659
Mechanical ventilation, n (%) 21 (20.6) 33 (56.9) 4.97 (2.45-10.08) <0.001c
Surfactant, n (%) 35 (34.3) 46 (79.3) 7.12 (3.34-15.17) <0.001c
Postnatal steroid, n (%) 23 (22.5) 20 (34.5) 1.81 (0.89-3.69) 0.104
Antenatal steroid, n (%) 11 (10.8) 5 (8.6) 0.78 (0.26-2.36) 0.658
Pre-eclampsia, n (%) 14 (13.7) 7 (12.1) 0.86 (0.33-2.28) 0.766
Premature rupture of the membranes (>24 h), n (%) 14 (13.7) 10 (17.2) 1.31 (0.54-3.17) 0.550
Values are median [min-max range]; BPD bronchopulmonary dysplasia, CI confidence interval, CPAP continuous positive airway pressure, SNAP the score for
neonatal acute physiology.
*Potential perinatal risk factors obtained during the first 72 hours of life were studied. #Data from all preterm infants (n =160) were analyzed to predict BPD or
death (n =58). Preterm infants who died or developed mild, moderate, or severe BPD were combined into one group.
aOdds ratio represents the increase in risk per 100 g increase in birth weight. bThe association did not remain significant after controlling for gestational age.
cThe association remained significant after controlling for gestational age. dOdds ratio per 1-point increase in SNAP. eRespiratory support was assigned as none,
nasal cannula, nasal CPAP, or invasive mechanical ventilation.
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death (p =0.996).
Preterm infants with adverse outcome of BPD or
death were more likely than controls to have a lower
gestational age at delivery, lower birth weight, lower
5 min-Apgar score, and higher SNAP score (Table 1).
The impact of SNAP (Odds ratio [OR] per 1-point in-
crease = 1.27, 95% confidence interval [CI] 1.13-1.41,
p <0.001) and 5 min- Apgar score (OR 0.72, 95% CI
0.57-0.91, p =0.005) persisted when controlling for ges-
tational age. Birth weight, however, did not remain
associated with BPD or death when adjusted for gesta-
tional age. Gender and 1 min- Apgar score were not
associated with BPD or death at the unadjusted bivari-
ate level. Furthermore, SNAP (OR 1.21, 95% CI 1.07-
1.39, p =0.004), 5 min-Apgar score (OR 0.59, 95% CI
0.43-0.81, p =0.001) and gestational age (OR 0.37, 95%
CI 0.23-0.58, p <0.001) remained associated with BPD
or death after controlling for the severity of BPD.Among infants with BPD or death, apnea of prematurity,
RDS, and PDA were observed more frequently than in the
control group. The association of RDS and PDA with BPD
or death remained significant after controlling for gesta-
tional age. In contrast, the presence of early onset sepsis,
hypoxic-ischemic brain damage, IVH, NEC or pneumo-
thorax was not associated with BPD or death.
Preterm infants with BPD or death were much more
likely than controls to have received oxygen therapy and
to be exposed to mechanical ventilation. Although we
did not find an association between nasal CPAP and
BPD or death, there was a significant association of re-
spiratory support included nasal cannula, nasal CPAP,
and invasive mechanical ventilation with BPD or death.
Moreover, BPD or death cases had more surfactant
treatment than controls. After adjustment for gestational
age, surfactant use was associated with a seven-fold in-
creased risk of BPD or death (OR 6.71, 95% CI 2.70-
16.63, p <0.001). There was no association between pre-
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use and BPD or death.
Multivariate analysis of risk factors for the development
of BPD or death
Variables with p <0.2 in the bivariate analysis were en-
tered into a backward stepwise multivariate logistic re-
gression analysis to identify the factors independently
associated with increased risk of BPD or death in criti-
cally ill preterm infants. The final model retained ges-
tational age, SNAP, the presence of apnea of prematurity
and PDA, and surfactant use as significant predictors,
with 5 min- Apgar score as a confounder (p =0.071)
(Table 2). The Hosmer-Lemeshow goodness-of-fit test
for the final model was not significant (p =0.333), indi-
cating that the model fits the data adequately.
SNAP as predictor for BPD or death
Based on the above-mentioned association between
SNAP and adverse outcome of BPD or death, SNAP
could be a useful prognostic predictor in critically ill
preterm infants. To assess the potential to predict BPD
or death, we compared the predictive value of SNAP
with other prognostic predictors demonstrated by multi-
variate regression analysis (Table 3). Gestational age and
SNAP appeared to be significant predictors, and achieved
AUC of 0.83 (95% CI 0.76-0.89, p <0.001) and 0.78
(95% CI 0.70-0.85, p <0.001) respectively, for predicting
the development BPD or death. When combining SNAP
and gestational age, the predictive performance im-
proved (AUC 0.88, 95% CI 0.84 to 0.94, p <0.001) over
that of gestational age alone, but not reaching statistical
significance (p =0.178).
Multivariate logistic regression analysis resulted in a su-
perior final model containing variables of SNAP, gesta-
tional age, the presence of apnea of prematurity and PDA,
and surfactant use as independent risk factors. With anTable 2 Multivariate logistic regression final model
predicting BPD or deatha
Odds ratiob 95% CI P value
Gestational age 0.38 0.25-0.57 <0.001
SNAP 1.19c 1.04-1.32 0.010
Apnea of prematurity 4.89 1.18-20.36 0.029
Patent ductus arteriosus 16.51 1.08-252.49 0.044
Surfactant use 7.99 2.33-27.47 0.001
Apgar score, 5 min 0.77 0.59-1.02 0.071
BPD bronchopulmonary dysplasia, CI confidence interval, SNAP the score for
neonatal acute physiology.
aVariables with P <0.2 in the unadjusted analysis (Table 1) were entered into a
backward stepwise multivariate logistic regression analysis. bData from all
preterm infants (n =160) were analyzed to predict BPD or death (n =58).
cOdds ratio per 1-point increase in SNAP.
The p value of the Hosmer-Lemeshow goodness-of-fit test for the final model
was 0.333.AUC of 0.92 (95% CI 0.87-0.96, p <0.001), the prognostic
accuracy of the final model was superior to the accuracy
of the other predictors. By using the nonparametric
method of Delong, the prognostic performance of the final
model was significantly better than gestational age
(p =0.026) or SNAP (p =0.002) alone. Figure 1 shows the
ROC curves and AUC for the final model and for SNAP
and gestational age.
The sensitivity and specificity of risk factors for the de-
velopment of BPD or death are shown in Table 4. SNAP
displayed sensitivity of 79% and specificity of 71% to pre-
dict BPD or death at the optimal cut-off score of 10.5,
and the positive and negative likelihood ratios were 2.7
and 0.29, respectively. Gestational age displayed sensitiv-
ity 81% and specificity 73% at the optimal cut-off value
of 31 weeks for predicting the development of BPD or
death, with the positive and negative likelihood ratios of
3.0 and 0.26, respectively. When combining the variables
of SNAP and gestational age, the sensitivity and specifi-
city increased to 84% and 77%, with the positive and
negative likelihood ratios of 3.8 and 0.20, respectively.
Meanwhile, when we combined the variables of SNAP,
gestational age, apnea of prematurity, PDA, and surfac-
tant use in the final model, specificity increased to 90%,
and positive likelihood ratio increased to 7.4.
Discussion
Our data demonstrate that the SNAP score based on 28
items collected during the first 24 hours of admission to
NICU is significantly associated with the development of
BPD or death in critically ill preterm infants with less
than 33 gestational weeks. High SNAP score is predict-
ive of BPD or death, and adds predictive value to other
potential perinatal risk factors in this population.
The present study first confirmed the known strong
association between low gestational age and BPD [6,7,9].
Infants with lower gestational age have worse outcomes.
The gestational age displayed the best predictive per-
formance, when compared with other perinatal risk fac-
tors determined by bivariate analysis. Our study is the
first to compare the predictive value of candidate peri-
natal risk factors obtained during the first 72 hours of
life, for the early prediction of BPD or death. Our find-
ings are in agreement with a large multicenter study,
which has reported that the gestational age was the most
predictive information for BPD risk on postnatal days 1
and 3 in infants of 23–30 weeks’ gestational age [9].
The major finding in the study was that the SNAP
score was significantly associated with adverse outcome
of BPD or death. For each point increment in the SNAP
score, the odds ratio for predicting BPD or death was
1.28. The SNAP score, based on 28 items from a variety
of sources including every body system and selected
blood test results, reflects the full clinical picture of an
Table 3 Predicting performance of SNAP and other risk factors for development of BPD or death
AUC 95% CI P value
Low gestational age 0.83 0.76-0.89 <0.001
SNAP 0.78 0.70-0.85 <0.001
Surfactant use 0.72 0.64-0.80 <0.001
Apnea of prematurity 0.59 0.50-0.69 0.050
Patent ductus arteriosus 0.57 0.47-0.66 0.174
SNAP, combined with gestational age 0.88 0.84-0.94 <0.001
SNAP, combined with surfactant use 0.81 0.75-0.88 <0.001
SNAP, combined with gestational age and surfactant use 0.90 0.85-0.95 <0.001
Combination of 5 risk factorsa 0.92 0.87-0.96 <0.001
P value (comparison of the difference between AUCs)
p = 0.352 (between SNAP and gestational age)
p = 0.178 (between SNAP combined with gestational age and gestational age alone)
p = 0.023 (between SNAP combined with gestational age and SNAP alone)
p = 0.026 (between combination of 5 risk factors and gestational age alone)
P = 0.002 (between combination of 5 risk factors and SNAP alone)
p = 0.362 (between combination of 5 risk factors and SNAP combined with gestational age)
AUC area under the receiver-operating-characteristic curve, BPD bronchopulmonary dysplasia, CI confidence interval, SNAP the score for neonatal acute physiology.
aFive risk factors: gestational age, SNAP, surfactant use, apnea of prematurity, and patent ductus arteriosus.
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suggest that considering the full clinical picture of an
infant is likely beneficial in the prediction of neonatal
mortality and morbidity [12,16-19]. One study evaluated
the usefulness of SNAP version II (SNAP-II) to predict
BPD [37], suggesting SNAP-II predicts chronic lung dis-
ease in the NICU. SNAP-II is a simpler version of SNAP
and reduces the number of variables to six [12]. This
previous study, however, excluded infants who died,
which is a competing outcome for BPD.
The SNAP score and gestational age contributed inde-
pendently to the risk of BPD or death. Although the pre-
dictive accuracy of SNAP for BPD or death (AUC of
0.78) was not better than that of gestational age (AUC of
0.83), the addition of SNAP improved BPD or death pre-
diction of gestational age (AUC of 0.88), increasing the
contribution of gestational age to BPD or death. This
suggests that SNAP was not a confounder here, but was
probably an effect modifier. In addition, the combination
of gestational age, apnea of prematurity, PDA, surfactant
use and SNAP appeared to be the best predictive model
for BPD or death in critically ill preterm infants, with an
AUC of 0.92. Our data indicate that SNAP, as a measure
of newborn illness severity, could add predictive value to
other previously described perinatal risk factors for BPD
or death.
Previously identified risk factors for BPD, including
gestational age, apnea of prematurity, PDA, and surfac-
tant use, were included in our final model [5,7,9,38].Surfactant therapy is a standard of care for infants at risk
of RDS. Although current evidence is insufficient to sup-
port surfactant treatment strategies for the prevention of
BPD [4,39], the surfactant with brief ventilation as part
of the intubation surfactant extubation approach was
found to reduce the rates of BPD [40]. Surfactant use
included in the model is likely not causal for BPD or
death but reflective of respiratory illness or management.
Previously described risk factors, including birth weight,
male gender, sepsis, oxygen therapy, and mechanical venti-
lation, were not included in the model [5,7,9,21,41]. None
of these factors improved prediction of the risk of BPD or
death after adjustment for the five critical risk factors. The
comparison of the prognostic value of SNAP to the pre-
dictive ability of known risk factors on the adverse out-
come of critically ill preterm infants is a novel aspect of
this work. Our findings suggest that the additional predic-
tive value of combining SNAP with known perinatal risk
factors improves the quantification of the risk for predic-
tion of neonatal mortality and morbidity.
Neonatal care has changed dramatically over the past
decades, and the improvement in antenatal corticoster-
oid treatment, surfactant replacement therapy and venti-
lator support greatly reduced the severity of long-term
respiratory morbidity and mortality. Despite that, the
risk of developing BPD remains high [42]. The overall
aim of the clinical research is to identify novel prevent-
ive and therapeutic strategies for BPD. It has been docu-
mented that vitamin A supplementation in extremely
Figure 1 Receiver operating characteristic curves for the ability of the score for neonatal acute physiology (SNAP), gestational age and
the models to predict the development of bronchopulmonary dysplasia or death in critically ill preterm infants with less than 33
gestational weeks (n =160). The area under the receiver operating characteristic curve for gestational age, SNAP, SNAP combined with
gestational age, and SNAP combined with gestational age, apnea of prematurity, patent ductus arteriosus, and surfactant use were 0.83, 0.78, 0.88
and 0.92, respectively, with a Hosmer-Lemeshow goodness-of-fit p value >0.05.
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of prematurity are effective in reducing the incidence
of BPD [39]. Our findings will contribute to identifying
preterm infants at high risk of BPD who could benefit
the most from the prophylactic administration of vitamin
A and caffeine during the early period of life. In addition,
our study focused on the early postnatal period, which is
clinically relevant. Previous studies suggested that the ben-
efits of postnatal treatment strategies might be dependent
on the baseline risk of BPD or death [9,43].
There were several limitations to our study. First, this
was a single-center study. Our results might be biasedTable 4 Predictive characteristics of SNAP and other risk facto
Cut-off value Sensitiv
Gestational age 31 weeks 81%
SNAP score 10.5 79%
SNAP, combined with gestational age 84%
Combination of 5 risk factorsa 77%
BPD bronchopulmonary dysplasia, LR + likelihood ratio positive, LR- likelihood ratio
the score for neonatal acute physiology.
aFive risk factors: gestational age, SNAP, surfactant use, apnea of prematurity, and pdue to the small sample size. There was a wide confi-
dence interval for odds ratio of apnea of prematurity, PDA
and surfactant use for BPD or death in the final model,
which might be in part attributed to a low incidence re-
lated to the small sample size. Second, we excluded 44 in-
fants who were unexpectedly discharged before the time
of BPD screening because of economic reasons, although
demographic and clinical characteristics of infants in-
cluded in the analyses were comparable with those being
excluded, as shown in the results. Furthermore, the ratio
of male to female in the study population was 1.9:1 (104/
56). During the study period, the gender ratio of male tors for BPD or death
ity Specificity PPV NPV LR+ LR-
73% 75% 79% 3.0 0.26
71% 73% 77% 2.7 0.29
77% 79% 83% 3.8 0.20
90% 88% 80% 7.4 0.25
negative, NPV negative predictive value, PPV positive predictive value, SNAP
atent ductus arteriosus.
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was 1.5:1. We were not able to determine the effects of
gender differences. These factors may lead to the potential
of selection bias and limit the generalizability of our re-
sults to similar patient populations in other NICUs. The
results of the study should be confirmed in a multicenter
study. Third, SNAP, unlike SNAP-II and the clinical risk
for babies score (CRIB), is cumbersome to use in clinical
practice. SNAP-II is scored within the first 12 hours of ad-
mission, and thus limited in practical use. The CRIB score
is only created to predict mortality for infants born at less
than 32 weeks gestation at birth [12].
Conclusions
In the study, high SNAP scores were significantly associ-
ated with increased risk for BPD or death in critically ill
preterm infants with less than 33 gestational weeks. SNAP
is predictive of BPD or death, with additional prognostic
value when used in conjunction with other perinatal risk
factors. The combination of SNAP score with gestational
age, apnea of prematurity, PDA, and surfactant use appears
to be the best predictive model for BPD or death during
the early postnatal period in this population. Large studies
are needed to further explore the role of the SNAP score
for prediction of BPD or death in neonates.
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